Dr. Peter Block and presenter Dr. Vera Bittner discuss lipoprotein(a) lowering by alirocumab contributes to total events reduction Independent of LDL (ODYSSEY OUTCOMES). Visit http://www.acc.org/ACC19 for full meeting coverage. - Acute Coronary Syndromes - 58_5feba5631406a

ODYSSEY OUTCOMES | ACC.19

ODYSSEY OUTCOMES | ACC.19

15 Views
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:


Dr. Peter Block and presenter Dr. Vera Bittner discuss lipoprotein(a) lowering by alirocumab contributes to total events reduction Independent of LDL (ODYSSEY OUTCOMES). Visit http://www.acc.org/ACC19 for full meeting coverage.

Up Next Autoplay